Tags : Adaptive Biotechnologies

Biotech COVID-19

Amgen and Adaptive Biotechnologies Collaborate to Develop Therapies Targeting COVID-19

Shots: The collaboration leverages Adaptive’s immune medicine platform for the identification of virus-neutralizing Abs with Amgen’s proficiency in immunology and novel Abs development Adaptive extends immune medicine platform to discover Abs from recovered COVID-19 patients, which enables the company to identify Abs from survivors of COVID-19 to select those that neutralize SARS-CoV-2 Amgen will leverage […]Read More

COVID-19 DigiHealth

Microsoft and Adaptive Biotechnologies Expand Their Collaboration for Mapping the

Shots: The companies collaborate on mapping the immune system’s response to threats, including the COVID-19 threat The focus of the alliance is to study population-wide immune responses to the COVID-19 with their findings to be publicly available via an open data portal. Following the study of immune responses, the companies expected to provide unique insight […]Read More